Literature DB >> 17292872

Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors.

Alessandro Valli1, Mohamed E Suliman, Natalie Meert, Raymond Vanholder, Bengt Lindholm, Peter Stenvinkel, Makoto Watanabe, Peter Barany, Anders Alvestrand, Björn Anderstam.   

Abstract

BACKGROUND: Advanced oxidation protein products (AOPP), a suggested protein biomarker of oxidative stress, are elevated in patients with chronic kidney disease (CKD), who also often suffer from hypertriglyceridemia.
METHODS: The analysis included plasma AOPP, TG, cholesterol, albumin and total protein, inflammation and oxidative stress markers from healthy subjects, non-dialyzed CKD, HD and CAPD patients. We studied, at two different European centres, effects of a meal, comparison between serum and plasma, L-index (indicating turbidity), spiking with fat and protein, and centrifugation on the AOPP concentrations. AOPP was measured at 340 nm and expressed as chloramine-T equivalents.
RESULTS: AOPP correlated with TG levels not only in CKD patients, but also in healthy subjects. Weak to absent correlations were observed between AOPP and markers of inflammation and oxidative stress in CKD patients. A meal increased the TG levels several-fold paralleled by a rise in measured AOPP to patient levels. Spiking of the plasma with Intralipid or protein resulted in increased absorbances at 340 nm, due to turbidity or real absorbance, while centrifugation similarly decreased the apparent AOPP and TG levels.
CONCLUSIONS: AOPP concentration, especially due to the influence of turbidity at all levels of TG concentration, but also due to other factors on top of TG, is overestimated in all plasma samples, including controls at fasting and non-fasting conditions. Thus, AOPP is a questionable biomarker of oxidative stress and inflammation in CKD patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17292872     DOI: 10.1016/j.cca.2006.12.026

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  14 in total

1.  Renal expression of advanced oxidative protein products predicts progression of renal fibrosis in patients with IgA nephropathy.

Authors:  Jun Wang; Min Liang; Jie Xu; Wei Cao; Guo B Wang; Zhan M Zhou; Jian W Tian; Nan Jia; Zhenhai Zhang; Jing Nie; Youhua Liu; Fan F Hou
Journal:  Lab Invest       Date:  2014-07-28       Impact factor: 5.662

2.  Increased Levels of Modified Advanced Oxidation Protein Products Are Associated with Central and Peripheral Blood Pressure in Peritoneal Dialysis Patients.

Authors:  Hong Xu; Ivan Cabezas-Rodriguez; Abdul Rashid Qureshi; Olof Heimburger; Peter Barany; Sunna Snaedal; Björn Anderstam; Ann-Christin Bragfors Helin; Juan Jesus Carrero; Peter Stenvinkel; Bengt Lindholm
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

3.  Nutritional status, energy expenditure, and protein oxidative stress after kidney transplantation.

Authors:  Larissa Vieira Marino; Elen Almeida Romão; Paula Garcia Chiarello
Journal:  Redox Rep       Date:  2017-05-12       Impact factor: 4.412

Review 4.  Protein-energy wasting and mortality in chronic kidney disease.

Authors:  Alice Bonanni; Irene Mannucci; Daniela Verzola; Antonella Sofia; Stefano Saffioti; Ezio Gianetta; Giacomo Garibotto
Journal:  Int J Environ Res Public Health       Date:  2011-05-19       Impact factor: 3.390

5.  Optimisation of an Advanced Oxidation Protein Products Assay: Its Application to Studies of Oxidative Stress in Diabetes Mellitus.

Authors:  Emma L Taylor; Kenneth R Armstrong; David Perrett; Andrew T Hattersley; Paul G Winyard
Journal:  Oxid Med Cell Longev       Date:  2015-05-14       Impact factor: 6.543

Review 6.  Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update.

Authors:  Raymond Vanholder; Anneleen Pletinck; Eva Schepers; Griet Glorieux
Journal:  Toxins (Basel)       Date:  2018-01-08       Impact factor: 4.546

7.  Association between serum advanced oxidation protein products and mortality risk in maintenance hemodialysis patients.

Authors:  Chun Zhou; Yuanyuan Zhang; Jianghua Chen; Changlin Mei; Fei Xiong; Wei Shi; Wei Zhou; Xusheng Liu; Shiren Sun; Jianwei Tian; Ziliang Ye; Qimeng Wu; Xianhui Qin; Jianping Jiang; Fan Fan Hou
Journal:  J Transl Med       Date:  2021-06-30       Impact factor: 5.531

Review 8.  What is new in uremic toxicity?

Authors:  Raymond Vanholder; Steven Van Laecke; Griet Glorieux
Journal:  Pediatr Nephrol       Date:  2008-03-07       Impact factor: 3.714

Review 9.  Oxidant/Antioxidant Balance in Animal Nutrition and Health: The Role of Protein Oxidation.

Authors:  Pietro Celi; Gianfranco Gabai
Journal:  Front Vet Sci       Date:  2015-10-26

10.  Advanced Oxidation Protein Products and Carbonylated Proteins as Biomarkers of Oxidative Stress in Selected Atherosclerosis-Mediated Diseases.

Authors:  Bogna Gryszczyńska; Dorota Formanowicz; Magdalena Budzyń; Maria Wanic-Kossowska; Elżbieta Pawliczak; Piotr Formanowicz; Wacław Majewski; Krzysztof Wojciech Strzyżewski; Magdalena P Kasprzak; Maria Iskra
Journal:  Biomed Res Int       Date:  2017-08-13       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.